Thompson Marlo K, Sharma Nidhi, Prakash Aishwarya
bioRxiv. 2023 Aug 7:2023.08.07.552313. doi: 10.1101/2023.08.07.552313.
Nanobodies or VHHs (Variable Heavy domains of Heavy chain) are single domain antibodies that comprise three antigenic complementary determining regions (CDR). Nanobodies are used in numerous scientific applications including, bio-imaging, diagnosis, therapeutics, and macromolecular crystallography. We obtained crystals of a ∼14 kDa nanobody specific for the NEIL1 DNA glycosylase (hereafter called A5) in 0.5 M ammonium sulfate, 0.1 M sodium citrate tribasic dihydrate pH 5.6, and 1.0 M lithium sulfate monohydrate from the Crystal HT Hampton Research screen that were further optimized. Here, we describe the structure determination and refinement of the A5 crystals to a resolution of 2.1 Å. The data collected were complicated by the presence of anisotropy and twinning, and while initial space group determination pointed to a higher apparent tetragonal crystal system, the data statistics suggested twinning, placing the crystal in an orthorhombic system. Twinning was confirmed by the Padilla and Yeates test, H-test, and Britton test based on local intensity differences with a twin fraction of 0.4. Molecular replacement produced the best solution in the orthorhombic space group P2 2 2 with four molecules in the asymmetric unit and we were able to model over 96% of the residues in the electron density with a final R and R of 0.1988 and 0.2289 upon refinement.
The crystal structure of a specific nanobody against NEIL1 was determined to 2.1 Å. The structure was ultimately solved in an orthorhombic space group after diffraction data analysis revealed mild anisotropy as well as pseudo-merohedral twinning.
纳米抗体或VHH(重链可变重域)是包含三个抗原互补决定区(CDR)的单域抗体。纳米抗体被用于众多科学应用中,包括生物成像、诊断、治疗以及大分子晶体学。我们从Hampton Research公司的Crystal HT筛选试剂盒中获得了一种针对NEIL1 DNA糖基化酶的约14 kDa纳米抗体(以下简称A5)的晶体,该晶体存在于0.5 M硫酸铵、0.1 M柠檬酸三钠二水合物(pH 5.6)和1.0 M一水硫酸锂中,并进一步进行了优化。在此,我们描述了A5晶体的结构测定和精修,分辨率达到2.1 Å。收集到的数据因存在各向异性和孪晶而变得复杂,虽然初始空间群测定表明晶体系统为明显的四方晶系,但数据统计表明存在孪晶,将晶体置于正交晶系中。基于局部强度差异,通过帕迪拉和耶茨检验、H检验以及布里顿检验证实了孪晶,孪晶分数为0.4。分子置换在正交空间群P2 2 2中产生了最佳解决方案,不对称单元中有四个分子,经过精修,我们能够在电子密度中对超过96%的残基进行建模,最终R 和R 分别为0.1988和0.2289。
确定了一种针对NEIL1的特异性纳米抗体的晶体结构,分辨率为2.1 Å。在衍射数据分析揭示出轻微的各向异性以及假准面孪晶后,最终在正交空间群中解析出该结构。